Literature DB >> 17162227

Noninvasive evaluation of liver disease severity.

John Carl Hoefs1, Phillip T Chen, Paul Lizotte.   

Abstract

In assessing the severity of chronic liver disease, one measures either the fibrotic structure of the liver or liver function. This article reviews the methods for evaluating the severity of liver disease noninvasively by estimating function or structure.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17162227     DOI： 10.1016/j.cld.2006.08.008

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN： 1089-3261            Impact factor:   6.126


  3 in total

1.  Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial.

Authors:  Gregory T Everson; Mitchell L Shiffman; John C Hoefs; Timothy R Morgan; Richard K Sterling; David A Wagner; Shannon Lauriski; Teresa M Curto; Anne Stoddard; Elizabeth C Wright
Journal:  Hepatology       Date:  2012-03-01       Impact factor: 17.425

2.  Very low viral load (VLVL) relapse following treatment of naïve patients with chronic hepatitis C.

Authors:  John Carl Hoefs; Vikramjit S Aulakh; Bernard Joseph Ilagan
Journal:  Dig Dis Sci       Date:  2011-12-04       Impact factor: 3.199

3.  A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury.

Authors:  Govardhana Rao Yannam; Bing Han; Kentaro Setoyama; Toshiyuki Yamamoto; Ryotaro Ito; Jenna M Brooks; Jorge Guzman-Lepe; Csaba Galambos; Jason V Fong; Melvin Deutsch; Mubina A Quader; Kosho Yamanouchi; Rafi Kabarriti; Keyur Mehta; Alejandro Soto-Gutierrez; Jayanta Roy-Chowdhury; Joseph Locker; Michio Abe; Charles A Enke; Janina Baranowska-Kortylewicz; Timothy D Solberg; Chandan Guha; Ira J Fox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-12-05       Impact factor: 7.038
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.